Part 2 and payment disclosures
The updated Part 2 rule allows a single patient consent covering treatment, payment, and health care operations. Counseling notes kept separately need their own consent, so the billing team should never rely on them.
Part 2 consent now shapes every substance use claim
Substance use treatment records carry federal confidentiality rules that affect what can be shared for payment, and providers had to meet the updated Part 2 rule by February 16, 2026. Taiga works with mental health practices, drafting codes from notes for clinician approval and working every denial. Residential and facility claims need a closer fit check.
Book a demoWhat sets substance use billing apart
Confidentiality, bundled codes, and state Medicaid rules all touch the claim.
Office-based opioid treatment
Medicare pays monthly bundles for office-based opioid use disorder care with HCPCS G2086, G2087, and G2088, covering management, care coordination, and therapy. Certified opioid treatment programs bill weekly bundles instead.
Residential care and Medicaid
Medicaid generally excludes care in large residential facilities classed as institutions for mental diseases. Many states use section 1115 demonstrations to pay for short-term residential treatment, so rules vary by state.
How a substance use handoff works
Clinical records and consent stay under your program's control.
Program keeps
Consents, treatment plans, counseling records, medication management notes, and approval of every code before submission.
Taiga takes on
Eligibility checks, claim scrubbing and submission, patient statements, and work on every denial and appeal for outpatient services.
Boundary to settle
Confirm your consent forms cover payment disclosures, and decide who owns residential per diem claims, state authorizations, and any grant-funded services.
Questions for a substance use fit call
Use de-identified examples only, given the extra confidentiality rules. Do not add patient details to the booking form.
What levels of care do you offer?
Separate office-based treatment, medication for opioid use disorder, intensive outpatient, and residential services.
Who pays for what?
Break out Medicaid and managed Medicaid, commercial plans, Medicare, state funding, and self-pay.
How is consent captured?
Describe your current Part 2 consent forms and when patients sign them.
Who this fits
Outpatient addiction and recovery practices that bill insurance and want claims and appeals handled by an experienced team. Medication management for opioid use disorder fits the same conversation.
Scope note
Residential programs bill differently by state and payer, often as facility claims. Taiga support for residential billing is not established, so confirm those lines before counting them in scope.
Questions about substance use treatment billing
Does Taiga work with substance use treatment practices?
Outpatient substance use care falls within the mental health work Taiga supports. Residential and facility billing needs a separate fit check.
What changed under the new Part 2 rule?
Patients can now sign one consent for all future uses and disclosures for treatment, payment, and health care operations. Compliance with the updated rule was required by February 16, 2026.
Which Medicare codes cover office-based opioid treatment?
HCPCS G2086, G2087, and G2088 describe monthly office-based opioid use disorder treatment, including management, care coordination, and psychotherapy.
Will Medicaid pay for residential substance use treatment?
It depends on the state. Medicaid generally excludes care in institutions for mental diseases, but many states have section 1115 demonstrations that cover short-term residential stays.
Bring your program's service mix
Share your levels of care and payers. Taiga will tell you straight which parts fit.
System guides show possible billing handoffs, not proven specialty compatibility.